Assenagon Asset Management S.A. lessened its position in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 52.1% in the first quarter, HoldingsChannel reports. The fund owned 1,097,559 shares of the enterprise software provider’s stock after selling 1,193,499 shares during the period. Assenagon Asset Management S.A.’s holdings in Oracle were worth $161,462,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. HFM Investment Advisors LLC boosted its stake in Oracle by 290.9% in the 4th quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock valued at $25,000 after purchasing an additional 96 shares during the period. Basepoint Wealth LLC acquired a new stake in shares of Oracle during the fourth quarter worth $26,000. FSA Wealth Management LLC acquired a new stake in shares of Oracle during the third quarter worth $28,000. Osbon Capital Management LLC bought a new stake in shares of Oracle in the fourth quarter valued at about $28,000. Finally, Joseph Group Capital Management acquired a new position in shares of Oracle in the fourth quarter valued at about $29,000. Institutional investors and hedge funds own 42.44% of the company’s stock.
Oracle Price Performance
Shares of NYSE:ORCL opened at $157.38 on Thursday. The firm has a 50 day moving average of $190.16 and a 200-day moving average of $176.34. The stock has a market capitalization of $453.34 billion, a PE ratio of 27.00, a PEG ratio of 1.04 and a beta of 1.65. The company has a current ratio of 1.12, a quick ratio of 1.35 and a debt-to-equity ratio of 3.21. Oracle Corporation has a 12 month low of $134.57 and a 12 month high of $345.72.
Oracle Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 24th. Shareholders of record on Friday, July 10th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, July 10th. Oracle’s dividend payout ratio (DPR) is currently 34.31%.
Analysts Set New Price Targets
ORCL has been the topic of a number of recent research reports. TD Cowen raised their price target on shares of Oracle from $250.00 to $300.00 and gave the stock a “buy” rating in a research report on Monday, June 8th. UBS Group increased their target price on shares of Oracle from $250.00 to $285.00 and gave the stock a “buy” rating in a research report on Tuesday, June 2nd. Citigroup reaffirmed a “market outperform” rating on shares of Oracle in a report on Thursday, June 11th. Barclays lifted their price target on shares of Oracle from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Finally, BMO Capital Markets boosted their price target on Oracle from $200.00 to $220.00 and gave the company an “outperform” rating in a research note on Thursday, June 11th. Two research analysts have rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $268.27.
Check Out Our Latest Research Report on ORCL
Insider Activity
In other news, EVP Stuart Levey sold 15,000 shares of Oracle stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $176.19, for a total value of $2,642,850.00. Following the transaction, the executive vice president owned 3,429 shares in the company, valued at approximately $604,155.51. This trade represents a 81.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 40.90% of the company’s stock.
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle is still being viewed by some analysts as a major AI infrastructure winner, with commentary pointing to a massive AI backlog that could convert into revenue over the next several years. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Positive Sentiment: Oracle Health announced an AI collaboration with Theator to extend AI into operating rooms, which could support future growth in healthcare workflows, documentation, and billing automation. Oracle Health Extends AI into the Operating Room in Collaboration with Theator
- Neutral Sentiment: Several bullish articles argue Oracle’s recent sell-off may be overdone and that the stock could rebound if backlog conversion and cloud growth continue to improve investor confidence. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Neutral Sentiment: Oracle’s annual filing and follow-up coverage confirmed the workforce reductions were tied to broader AI adoption, but the company framed them as part of a restructuring effort rather than a sign of operational distress. Oracle Sheds 21,000 Jobs as It Continues AI-Focused Streamlining
- Negative Sentiment: Investors are worried that Oracle’s AI spending is being funded with more debt and that preferred stock conversions or ATM share issuance could dilute shareholders and weigh on the stock price. Oracle Analyst Warns: Preferred Stock Conversions and ATM Issuances May Dilute Shareholders and Pressure Stock Price
- Negative Sentiment: Broader tech weakness and an AI sector pullback are also adding to ORCL’s decline, as investors reassess high-spending AI names. Sector Update: Tech Stocks Fall Late Afternoon
About Oracle
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Further Reading
- Five stocks we like better than Oracle
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
